Purple Biotech (PPBT) Stock Forecast, Price Target & Predictions
PPBT Stock Forecast
Purple Biotech stock forecast is as follows:
Purple Biotech Financial Forecast
Purple Biotech Revenue Forecast
| Dec 24 | Sep 24 | Jun 24 | |
|---|---|---|---|
| Revenue | - | - | - |
| Avg Forecast | - | - | - |
| High Forecast | - | - | - |
| Low Forecast | - | - | - |
| # Analysts | - | - | - |
| Surprise % | - | - | - |
Purple Biotech's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. PPBT's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).
Purple Biotech EBITDA Forecast
| Dec 24 | Sep 24 | Jun 24 | |
|---|---|---|---|
| # Analysts | - | - | - |
| EBITDA | - | - | - |
| Avg Forecast | - | - | - |
| High Forecast | - | - | - |
| Low Forecast | - | - | - |
| Surprise % | - | - | - |
undefined analysts predict PPBT's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Purple Biotech's previous annual EBITDA (undefined) of $NaN.
Purple Biotech Net Income Forecast
| Dec 24 | Sep 24 | Jun 24 | |
|---|---|---|---|
| # Analysts | - | - | - |
| Net Income | - | - | - |
| Avg Forecast | $-1.11M | $-1.38M | $-3.18M |
| High Forecast | $-1.11M | $-1.38M | $-1.79M |
| Low Forecast | $-1.11M | $-1.38M | $-4.77M |
| Surprise % | - | - | - |
Purple Biotech's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. PPBT's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Purple Biotech SG&A Forecast
| Dec 24 | Sep 24 | Jun 24 | |
|---|---|---|---|
| # Analysts | - | - | - |
| SG&A | - | - | - |
| Avg Forecast | - | - | - |
| High Forecast | - | - | - |
| Low Forecast | - | - | - |
| Surprise % | - | - | - |
Purple Biotech's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to PPBT last annual SG&A of $NaN (undefined).
Purple Biotech EPS Forecast
| Dec 24 | Sep 24 | Jun 24 | |
|---|---|---|---|
| # Analysts | - | - | - |
| EPS | - | - | - |
| Avg Forecast | $-0.04 | $-0.05 | $-0.12 |
| High Forecast | $-0.04 | $-0.05 | $-0.06 |
| Low Forecast | $-0.04 | $-0.05 | $-0.17 |
| Surprise % | - | - | - |
According to undefined Wall Street analysts, Purple Biotech's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to PPBT previous annual EPS of $NaN (undefined).
Purple Biotech Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| PMVP | PMV Pharmaceuticals | $1.50 | $24.75 | 1550.00% | Buy |
| ENLV | Enlivex Therapeutics | $1.51 | $15.00 | 893.38% | Buy |
| BNOX | Bionomics | $0.66 | $6.00 | 809.09% | Buy |
| ANEB | Anebulo Pharmaceuticals | $2.27 | $6.00 | 164.32% | Buy |
| SABS | SAB Biotherapeutics | $2.77 | $5.67 | 104.69% | Buy |
| PPBT | Purple Biotech | $7.37 | $11.00 | 49.25% | - |
| SLNO | Soleno Therapeutics | $52.92 | $72.25 | 36.53% | Buy |
PPBT Forecast FAQ
What are Purple Biotech's analysts' financial forecasts?
PPBT's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $0 (high $0, low $0), average EBITDA is $0 (high $0, low $0), average net income is $-5.671M (high $-4.279M, low $-7.262M), average SG&A $0 (high $0, low $0), and average EPS is $-0.205 (high $-0.155, low $-0.262).